Population Impact of HPV Vaccines: Summary of Early Evidence

Abstract Human papillomavirus (HPV) vaccines are available in the United States and around the world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV vaccination is currently recommended for adolescents: target ages for routine and catch-up vaccinations vary by cou...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of adolescent health 2013-12, Vol.53 (6), p.679-682
Main Authors:	Hariri, Susan, Ph.D, Markowitz, Lauri E., M.D, Dunne, Eileen F., M.D., M.P.H, Unger, Elizabeth R., M.D., Ph.D
Format:	Article
Language:	eng
Subjects:	Adolescent Adult Cervical cancer Condylomata Acuminata - epidemiology Condylomata Acuminata - prevention & control Condylomata Acuminata - virology Female Genitals Global Health HPV vaccine Human papillomavirus Human papillomaviruses Humans Immunization Male Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Infections - virology Papillomavirus Vaccines Pediatrics Prevalence Prevention Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology Vaccines Warts
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract Human papillomavirus (HPV) vaccines are available in the United States and around the world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV vaccination is currently recommended for adolescents: target ages for routine and catch-up vaccinations vary by country. Because the time from vaccination to cancer development can be several decades, many studies are evaluating more immediate outcomes. In the 4 years since the vaccine was introduced, reductions in HPV vaccine type prevalence and genital warts have been reported in young females in the United States and other countries. Many questions remain about the long-term impact, but the initial studies show promising results for the relatively new HPV vaccine.
ISSN:	1054-139X 1879-1972